Global SGOT Test Market

SGOT Test Comprehensive Study by Type (Instruments, Kits and Reagents), Application (Hospitals, Specialty Clinics, Ambulatory Surgical Centre) Players and Region - Global Market Outlook to 2027

SGOT Test Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
SGOT Test Market Scope
The SGOT test is a blood test used to evaluate the liver. It measures serum glutamic-oxaloacetic transaminase, one of two liver enzymes. This enzyme is commonly referred to as AST, which stands for aspartate aminotransferase. An SGOT (or AST) test determines the amount of the liver enzyme in the blood. A SGOT test may be used to assist a doctor in diagnosing liver damage or disease. When liver cells are damaged, SGOT leaks into the bloodstream, increasing the level of this enzyme in the blood. The test may be used to assess liver health in people who are already known to have liver-related conditions, such as hepatitis C. SGOT can be found in many parts of the body, including the kidneys, muscles, and liver.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global SGOT Test market throughout the predicted period.

Alpha Laboratories (United Kingdom), Biobase Group (China), ELITechGroup (United States), Roche Diagnostics (United States), Randox Laboratories Ltd (United Kingdom), Abbott Laboratories (United States), AbbVie (United States), Portea Medical (India) and Thermo Fisher Scientific Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are TRUTEST Laboratories. (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global SGOT Test market by Type (Instruments and Kits and Reagents), by Application (Hospitals, Specialty Clinics and Ambulatory Surgical Centre) and Region with country level break-up.

On the basis of geography, the market of SGOT Test has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
On 1 March 2022, AbbVie announced it has completed the acquisition of Syndesi Therapeutics SA, which will help to expand AbbVie's neuroscience portfolio. This acquisition gives AbbVie access to Syndesi's portfolio of novel modulators of the synaptic vesicle protein 2A (SV2A), including its lead molecule SDI-118. The mechanism is currently being evaluated for the potential treatment of cognitive impairment and other symptoms associated with a range of neuropsychiatric and neurodegenerative disorders, such as Alzheimer's disease and major depressive disorder.



Market Trend
  • Increased Research And Development SGOT Testing Investments

Market Drivers
  • Rising Prevalence Of Liver Disease
  • High Growth In Geriatric Population

Opportunities
  • Increasing Opportunities From Developing Regions
  • Growth In The Healthcare Industry Worldwide

Restraints
  • Lack Of Awareness Associated With SGOT Testing

Challenges
  • Lack Of Trained Professional To Perform Proper Tests
  • High Cost Associated With SGOT Testing Instruments


Key Target Audience
New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Type
  • Instruments
  • Kits and Reagents
By Application
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centre
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence Of Liver Disease
      • 3.2.2. High Growth In Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Lack Of Trained Professional To Perform Proper Tests
      • 3.3.2. High Cost Associated With SGOT Testing Instruments
    • 3.4. Market Trends
      • 3.4.1. Increased Research And Development SGOT Testing Investments
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global SGOT Test, by Type, Application and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global SGOT Test (Value)
      • 5.2.1. Global SGOT Test by: Type (Value)
        • 5.2.1.1. Instruments
        • 5.2.1.2. Kits and Reagents
      • 5.2.2. Global SGOT Test by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Specialty Clinics
        • 5.2.2.3. Ambulatory Surgical Centre
      • 5.2.3. Global SGOT Test Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Australia
          • 5.2.3.2.6. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global SGOT Test (Price)
      • 5.3.1. Global SGOT Test by: Type (Price)
  • 6. SGOT Test: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Alpha Laboratories (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Biobase Group (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. ELITechGroup (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Roche Diagnostics (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Randox Laboratories Ltd (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Abbott Laboratories (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. AbbVie (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Portea Medical (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Thermo Fisher Scientific Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global SGOT Test Sale, by Type, Application and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global SGOT Test (Value)
      • 7.2.1. Global SGOT Test by: Type (Value)
        • 7.2.1.1. Instruments
        • 7.2.1.2. Kits and Reagents
      • 7.2.2. Global SGOT Test by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Specialty Clinics
        • 7.2.2.3. Ambulatory Surgical Centre
      • 7.2.3. Global SGOT Test Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Australia
          • 7.2.3.2.6. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global SGOT Test (Price)
      • 7.3.1. Global SGOT Test by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. SGOT Test: by Type(USD Million)
  • Table 2. SGOT Test Instruments , by Region USD Million (2016-2021)
  • Table 3. SGOT Test Kits and Reagents , by Region USD Million (2016-2021)
  • Table 4. SGOT Test: by Application(USD Million)
  • Table 5. SGOT Test Hospitals , by Region USD Million (2016-2021)
  • Table 6. SGOT Test Specialty Clinics , by Region USD Million (2016-2021)
  • Table 7. SGOT Test Ambulatory Surgical Centre , by Region USD Million (2016-2021)
  • Table 8. South America SGOT Test, by Country USD Million (2016-2021)
  • Table 9. South America SGOT Test, by Type USD Million (2016-2021)
  • Table 10. South America SGOT Test, by Application USD Million (2016-2021)
  • Table 11. Brazil SGOT Test, by Type USD Million (2016-2021)
  • Table 12. Brazil SGOT Test, by Application USD Million (2016-2021)
  • Table 13. Argentina SGOT Test, by Type USD Million (2016-2021)
  • Table 14. Argentina SGOT Test, by Application USD Million (2016-2021)
  • Table 15. Rest of South America SGOT Test, by Type USD Million (2016-2021)
  • Table 16. Rest of South America SGOT Test, by Application USD Million (2016-2021)
  • Table 17. Asia Pacific SGOT Test, by Country USD Million (2016-2021)
  • Table 18. Asia Pacific SGOT Test, by Type USD Million (2016-2021)
  • Table 19. Asia Pacific SGOT Test, by Application USD Million (2016-2021)
  • Table 20. China SGOT Test, by Type USD Million (2016-2021)
  • Table 21. China SGOT Test, by Application USD Million (2016-2021)
  • Table 22. Japan SGOT Test, by Type USD Million (2016-2021)
  • Table 23. Japan SGOT Test, by Application USD Million (2016-2021)
  • Table 24. India SGOT Test, by Type USD Million (2016-2021)
  • Table 25. India SGOT Test, by Application USD Million (2016-2021)
  • Table 26. South Korea SGOT Test, by Type USD Million (2016-2021)
  • Table 27. South Korea SGOT Test, by Application USD Million (2016-2021)
  • Table 28. Australia SGOT Test, by Type USD Million (2016-2021)
  • Table 29. Australia SGOT Test, by Application USD Million (2016-2021)
  • Table 30. Rest of Asia-Pacific SGOT Test, by Type USD Million (2016-2021)
  • Table 31. Rest of Asia-Pacific SGOT Test, by Application USD Million (2016-2021)
  • Table 32. Europe SGOT Test, by Country USD Million (2016-2021)
  • Table 33. Europe SGOT Test, by Type USD Million (2016-2021)
  • Table 34. Europe SGOT Test, by Application USD Million (2016-2021)
  • Table 35. Germany SGOT Test, by Type USD Million (2016-2021)
  • Table 36. Germany SGOT Test, by Application USD Million (2016-2021)
  • Table 37. France SGOT Test, by Type USD Million (2016-2021)
  • Table 38. France SGOT Test, by Application USD Million (2016-2021)
  • Table 39. Italy SGOT Test, by Type USD Million (2016-2021)
  • Table 40. Italy SGOT Test, by Application USD Million (2016-2021)
  • Table 41. United Kingdom SGOT Test, by Type USD Million (2016-2021)
  • Table 42. United Kingdom SGOT Test, by Application USD Million (2016-2021)
  • Table 43. Netherlands SGOT Test, by Type USD Million (2016-2021)
  • Table 44. Netherlands SGOT Test, by Application USD Million (2016-2021)
  • Table 45. Rest of Europe SGOT Test, by Type USD Million (2016-2021)
  • Table 46. Rest of Europe SGOT Test, by Application USD Million (2016-2021)
  • Table 47. MEA SGOT Test, by Country USD Million (2016-2021)
  • Table 48. MEA SGOT Test, by Type USD Million (2016-2021)
  • Table 49. MEA SGOT Test, by Application USD Million (2016-2021)
  • Table 50. Middle East SGOT Test, by Type USD Million (2016-2021)
  • Table 51. Middle East SGOT Test, by Application USD Million (2016-2021)
  • Table 52. Africa SGOT Test, by Type USD Million (2016-2021)
  • Table 53. Africa SGOT Test, by Application USD Million (2016-2021)
  • Table 54. North America SGOT Test, by Country USD Million (2016-2021)
  • Table 55. North America SGOT Test, by Type USD Million (2016-2021)
  • Table 56. North America SGOT Test, by Application USD Million (2016-2021)
  • Table 57. United States SGOT Test, by Type USD Million (2016-2021)
  • Table 58. United States SGOT Test, by Application USD Million (2016-2021)
  • Table 59. Canada SGOT Test, by Type USD Million (2016-2021)
  • Table 60. Canada SGOT Test, by Application USD Million (2016-2021)
  • Table 61. Mexico SGOT Test, by Type USD Million (2016-2021)
  • Table 62. Mexico SGOT Test, by Application USD Million (2016-2021)
  • Table 63. SGOT Test: by Type(USD/Units)
  • Table 64. Company Basic Information, Sales Area and Its Competitors
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. SGOT Test: by Type(USD Million)
  • Table 74. SGOT Test Instruments , by Region USD Million (2022-2027)
  • Table 75. SGOT Test Kits and Reagents , by Region USD Million (2022-2027)
  • Table 76. SGOT Test: by Application(USD Million)
  • Table 77. SGOT Test Hospitals , by Region USD Million (2022-2027)
  • Table 78. SGOT Test Specialty Clinics , by Region USD Million (2022-2027)
  • Table 79. SGOT Test Ambulatory Surgical Centre , by Region USD Million (2022-2027)
  • Table 80. South America SGOT Test, by Country USD Million (2022-2027)
  • Table 81. South America SGOT Test, by Type USD Million (2022-2027)
  • Table 82. South America SGOT Test, by Application USD Million (2022-2027)
  • Table 83. Brazil SGOT Test, by Type USD Million (2022-2027)
  • Table 84. Brazil SGOT Test, by Application USD Million (2022-2027)
  • Table 85. Argentina SGOT Test, by Type USD Million (2022-2027)
  • Table 86. Argentina SGOT Test, by Application USD Million (2022-2027)
  • Table 87. Rest of South America SGOT Test, by Type USD Million (2022-2027)
  • Table 88. Rest of South America SGOT Test, by Application USD Million (2022-2027)
  • Table 89. Asia Pacific SGOT Test, by Country USD Million (2022-2027)
  • Table 90. Asia Pacific SGOT Test, by Type USD Million (2022-2027)
  • Table 91. Asia Pacific SGOT Test, by Application USD Million (2022-2027)
  • Table 92. China SGOT Test, by Type USD Million (2022-2027)
  • Table 93. China SGOT Test, by Application USD Million (2022-2027)
  • Table 94. Japan SGOT Test, by Type USD Million (2022-2027)
  • Table 95. Japan SGOT Test, by Application USD Million (2022-2027)
  • Table 96. India SGOT Test, by Type USD Million (2022-2027)
  • Table 97. India SGOT Test, by Application USD Million (2022-2027)
  • Table 98. South Korea SGOT Test, by Type USD Million (2022-2027)
  • Table 99. South Korea SGOT Test, by Application USD Million (2022-2027)
  • Table 100. Australia SGOT Test, by Type USD Million (2022-2027)
  • Table 101. Australia SGOT Test, by Application USD Million (2022-2027)
  • Table 102. Rest of Asia-Pacific SGOT Test, by Type USD Million (2022-2027)
  • Table 103. Rest of Asia-Pacific SGOT Test, by Application USD Million (2022-2027)
  • Table 104. Europe SGOT Test, by Country USD Million (2022-2027)
  • Table 105. Europe SGOT Test, by Type USD Million (2022-2027)
  • Table 106. Europe SGOT Test, by Application USD Million (2022-2027)
  • Table 107. Germany SGOT Test, by Type USD Million (2022-2027)
  • Table 108. Germany SGOT Test, by Application USD Million (2022-2027)
  • Table 109. France SGOT Test, by Type USD Million (2022-2027)
  • Table 110. France SGOT Test, by Application USD Million (2022-2027)
  • Table 111. Italy SGOT Test, by Type USD Million (2022-2027)
  • Table 112. Italy SGOT Test, by Application USD Million (2022-2027)
  • Table 113. United Kingdom SGOT Test, by Type USD Million (2022-2027)
  • Table 114. United Kingdom SGOT Test, by Application USD Million (2022-2027)
  • Table 115. Netherlands SGOT Test, by Type USD Million (2022-2027)
  • Table 116. Netherlands SGOT Test, by Application USD Million (2022-2027)
  • Table 117. Rest of Europe SGOT Test, by Type USD Million (2022-2027)
  • Table 118. Rest of Europe SGOT Test, by Application USD Million (2022-2027)
  • Table 119. MEA SGOT Test, by Country USD Million (2022-2027)
  • Table 120. MEA SGOT Test, by Type USD Million (2022-2027)
  • Table 121. MEA SGOT Test, by Application USD Million (2022-2027)
  • Table 122. Middle East SGOT Test, by Type USD Million (2022-2027)
  • Table 123. Middle East SGOT Test, by Application USD Million (2022-2027)
  • Table 124. Africa SGOT Test, by Type USD Million (2022-2027)
  • Table 125. Africa SGOT Test, by Application USD Million (2022-2027)
  • Table 126. North America SGOT Test, by Country USD Million (2022-2027)
  • Table 127. North America SGOT Test, by Type USD Million (2022-2027)
  • Table 128. North America SGOT Test, by Application USD Million (2022-2027)
  • Table 129. United States SGOT Test, by Type USD Million (2022-2027)
  • Table 130. United States SGOT Test, by Application USD Million (2022-2027)
  • Table 131. Canada SGOT Test, by Type USD Million (2022-2027)
  • Table 132. Canada SGOT Test, by Application USD Million (2022-2027)
  • Table 133. Mexico SGOT Test, by Type USD Million (2022-2027)
  • Table 134. Mexico SGOT Test, by Application USD Million (2022-2027)
  • Table 135. SGOT Test: by Type(USD/Units)
  • Table 136. Research Programs/Design for This Report
  • Table 137. Key Data Information from Secondary Sources
  • Table 138. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global SGOT Test: by Type USD Million (2016-2021)
  • Figure 5. Global SGOT Test: by Application USD Million (2016-2021)
  • Figure 6. South America SGOT Test Share (%), by Country
  • Figure 7. Asia Pacific SGOT Test Share (%), by Country
  • Figure 8. Europe SGOT Test Share (%), by Country
  • Figure 9. MEA SGOT Test Share (%), by Country
  • Figure 10. North America SGOT Test Share (%), by Country
  • Figure 11. Global SGOT Test: by Type USD/Units (2016-2021)
  • Figure 12. Global SGOT Test share by Players 2021 (%)
  • Figure 13. Global SGOT Test share by Players (Top 3) 2021(%)
  • Figure 14. Global SGOT Test share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Alpha Laboratories (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 17. Alpha Laboratories (United Kingdom) Revenue: by Geography 2021
  • Figure 18. Biobase Group (China) Revenue, Net Income and Gross profit
  • Figure 19. Biobase Group (China) Revenue: by Geography 2021
  • Figure 20. ELITechGroup (United States) Revenue, Net Income and Gross profit
  • Figure 21. ELITechGroup (United States) Revenue: by Geography 2021
  • Figure 22. Roche Diagnostics (United States) Revenue, Net Income and Gross profit
  • Figure 23. Roche Diagnostics (United States) Revenue: by Geography 2021
  • Figure 24. Randox Laboratories Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. Randox Laboratories Ltd (United Kingdom) Revenue: by Geography 2021
  • Figure 26. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 27. Abbott Laboratories (United States) Revenue: by Geography 2021
  • Figure 28. AbbVie (United States) Revenue, Net Income and Gross profit
  • Figure 29. AbbVie (United States) Revenue: by Geography 2021
  • Figure 30. Portea Medical (India) Revenue, Net Income and Gross profit
  • Figure 31. Portea Medical (India) Revenue: by Geography 2021
  • Figure 32. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2021
  • Figure 34. Global SGOT Test: by Type USD Million (2022-2027)
  • Figure 35. Global SGOT Test: by Application USD Million (2022-2027)
  • Figure 36. South America SGOT Test Share (%), by Country
  • Figure 37. Asia Pacific SGOT Test Share (%), by Country
  • Figure 38. Europe SGOT Test Share (%), by Country
  • Figure 39. MEA SGOT Test Share (%), by Country
  • Figure 40. North America SGOT Test Share (%), by Country
  • Figure 41. Global SGOT Test: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Alpha Laboratories (United Kingdom)
  • Biobase Group (China)
  • ELITechGroup (United States)
  • Roche Diagnostics (United States)
  • Randox Laboratories Ltd (United Kingdom)
  • Abbott Laboratories (United States)
  • AbbVie (United States)
  • Portea Medical (India)
  • Thermo Fisher Scientific Inc. (United States)
Additional players considered in the study are as follows:
TRUTEST Laboratories. (United States)
Select User Access Type

Key Highlights of Report


May 2022 214 Pages 96 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global SGOT Test Market Quantitative research analysis
Global SGOT Test Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The SGOT Test study can be customized to meet your requirements. The market size breakdown by type [Instruments and Kits and Reagents], by end use application [Hospitals, Specialty Clinics and Ambulatory Surgical Centre].
The SGOT Test Market is gaining popularity and expected to see strong valuation by 2027 .
According to AMA, the Global SGOT Test market is expected to see growth rate of xx%.

Know More About Global SGOT Test Market Report?

Have a Query? Click Here

Other Related Reports

Narcotic Drugs Comprehensive Study by Type (Opium, Heroin, Demerol, Darvon, Others), Types (Stimulants (E.G. Cocaine), Depressants (E.G. Alcohol), Opium-Related Painkillers (E.G. Heroin), Hallucinoge...
$ 4000
Monkeypox Vaccine Comprehensive Study by Application (Adult, Child), Symptoms (Including Chills, Fever Headache, Muscle Weakness, Lymph Node Swelling, Exhaustion), End-use (Private Hospitals / Clinic...
$ 3800
Pediatric Digestive Drugs Comprehensive Study by Type (Global Pediatric Digestive Drugs Market Segment Percentages, by Type, 2021 (%)), Application (Gastroenteritis, Celiac disease, Crohn’s disease, ...
$ 3800
CBG Oil Comprehensive Study by Application (Skincare treatment, Mental Health treatment, Physical Health treatment, Other), Bottle (15ml, 30ml, Other), Mg (100mg -500mg, 600mg – 1100mg, 1200mg-1700mg...
$ 3800
Birthmarks Drugs Comprehensive Study by Application (Hospitals, Pharmaceuticals, Clinical laboratories), Forms (Tablets, Ointment, Powder, Liquid), Disease (Strawberry hemangiomas, Cavernous hemangio...
$ 3800
Hormone Deficiency Comprehensive Study by Application (Hospitals, Clinics), Medication (Genotropin, Humatrope, Norditropin, Other), Types of Hormonal Disorders (Adrenal, Parathyroid, Pancreas, Pituit...
$ 3800